Literature DB >> 10773252

Tumor bed cyst formation after BCNU wafer implantation: report of two cases.

H H Engelhard1.   

Abstract

BACKGROUND: Interstitial implantation of BCNU wafers is currently used to treat glioblastoma multiforme. Known complications of BCNU wafer implantation include abnormalities of wound healing (including CSF leak), edema formation, and intracranial infection. The purpose of this report is to alert neurosurgeons to an additional potential side effect: formation of a cystic mass within the implanted tumor bed. CASE PRESENTATIONS: Two patients are described: a 54-year-old male, who presented with a large right parieto-occipital mass, and a 47-year-old woman with a large right frontal lobe tumor. Both tumors were found on initial craniotomy to be glioblastoma multiforme; both recurred rapidly despite radiation therapy. Patients were treated with a second craniotomy for tumor resection and placement of BCNU wafers. After implantation, the first patient did well for 6 weeks, then developed lethargy, headaches, and vomiting. CT scan showed a large cyst at the craniotomy site; this required reoperation for drainage. The second patient had a seizure, deterioration of mental status, and progressive hemiparesis 10 days after wafer implantation. CT scan again showed that a large cyst had formed in the area of the previous surgery; she also required reoperation. In each case, minimal tumor and no evidence of infection were found. Within a few more weeks, each patient succumbed to progressive disease.
CONCLUSIONS: The hypodense, roughly spherical cysts clearly demonstrated clinically significant mass effect, and required reoperation despite treatment with high-dose corticosteroids. Neurosurgeons should be alert to the possibility of tumor bed cyst formation in patients treated with interstitial BCNU wafers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773252     DOI: 10.1016/s0090-3019(00)00162-2

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  9 in total

1.  Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma.

Authors:  Stephan Ulmer; Klara Spalek; Arya Nabavi; Susan Schultka; H Maximillian Mehdorn; Santosh Kesari; Lutz Dörner
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

Review 2.  Neurosurgical oncology: advances in operative technologies and adjuncts.

Authors:  Randy S D'Amico; Benjamin C Kennedy; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2014-06-27       Impact factor: 4.130

3.  Incorporating BCNU wafers into malignant glioma treatment: European case studies.

Authors:  Anne Balossier; Lutz Dörner; Evelyne Emery; Oliver Heese; H Maximilian Mehdorn; Philippe Menei; Jagmohan Singh
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

4.  Discriminating surgical bed cysts from bacterial brain abscesses after Carmustine wafer implantation in newly diagnosed IDH-wildtype glioblastomas.

Authors:  Alexandre Roux; Hichem Ammar; Alessandro Moiraghi; Sophie Peeters; Marwan Baroud; Gilles Zah-Bi; Joseph Benzakoun; Eduardo Parraga; Catherine Oppenheim; Chiara Benevello; Fabrice Chretien; Pascale Varlet; Frédéric Dhermain; Edouard Dezamis; Marc Zanello; Johan Pallud
Journal:  Neurosurg Rev       Date:  2021-10-14       Impact factor: 3.042

5.  Evaluation of serial changes on computed tomography and magnetic resonance imaging after implantation of carmustine wafers in patients with malignant gliomas for differential diagnosis of tumor recurrence.

Authors:  Shiro Ohue; Shohei Kohno; Akihiro Inoue; Daisuke Yamashita; Satoshi Suehiro; Toshimoto Seno; Yoshiaki Kumon; Keiichi Kikuchi; Takanori Ohnishi
Journal:  J Neurooncol       Date:  2015-09-18       Impact factor: 4.130

Review 6.  The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience.

Authors:  A Gutenberg; C B Lumenta; W E K Braunsdorf; M Sabel; H M Mehdorn; M Westphal; A Giese
Journal:  J Neurooncol       Date:  2013-03-28       Impact factor: 4.130

7.  Reoperation as a result of raised intracranial pressure associated with cyst formation in tumor cavity after intracranial tumor resection: a report of two cases.

Authors:  Jinlu Yu; Wenji Xiong; Limei Qu; Haiyan Huang
Journal:  Case Rep Med       Date:  2010-09-28

8.  Safety and efficacy of concomitant chemotherapeutic wafers and iodine-125 seeds for recurrent glioblastoma.

Authors:  Andrew L Ko; Kathleen R Fink; Keith M Stelzer; Daniel L Silbergeld
Journal:  Surg Neurol Int       Date:  2012-11-20

9.  Double-edged Sword in the Placement of Carmustine (BCNU) Wafers along the Eloquent Area: A Case Report.

Authors:  Shunichiro Kuramitsu; Kazuya Motomura; Atsushi Natsume; Toshihiko Wakabayashi
Journal:  NMC Case Rep J       Date:  2014-10-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.